The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

The FDA has granted accelerated approval for Wegovy for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis in adults.

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.

Studies have found that semaglutide, the chemical in Ozempic, reduced alcohol intake, binge drinking and relapse ...

Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...

Andersen has a fair value estimate of $71 for Novo stock. Closing around $52.41 on Aug. 15 (near its lowest level since ...

FDA has approved Novo Nordisk's Wegovy, one-weekly 2.4 mg semaglutide injection for treating metabolic-associated ...

A group of vaccine-skeptical doctors and mandate opponents is challenging the CDC’s childhood immunization schedule in ...

Obesity and overweight increase the risk of type 2 diabetes, hypertension, cardiovascular disease and stroke. The quality of ...

(Reuters) -Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying ...

Semaglutide aka Ozempic is officially approved for the treatment of adults with type 2 diabetes mellitus that is not ...

Semaglutide aka Ozempic is officially approved for the treatment of adults with type 2 diabetes mellitus that is not ...